「Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.」の関連論文
-
Early Alteration in Apparent Diffusion Coefficient and Tumor Volume in Cervical Cancer Treated with Chemoradiotherapy or Radiotherapy: Incremental Prognostic Value over Pretreatment Assessments
-
Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non–small cell lung cancer
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
-
Project 1 Analyzing Tumor Microenvironment and Exploiting its Characteristics in Search of Optimizing Cancer Therapy Including Neutron Capture Therapy (R2P1)
-
TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer
-
Outcomes of the Sequential Treatment of Unresectable Hepatocellular Carcinoma Using Lenvatinib
-
Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors
-
Clinical significance and biological role of L1 cell adhesion molecule in gastric cancer
-
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
-
Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy
-
Tumor volume shrinkage during stereotactic body radiotherapy is related to better prognoses in patients with stage I non-small-cell lung cancer
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
Systemic therapy for salivary gland malignancy: current status and future perspectives
-
The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer
-
DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-κB Pathway and Epithelial-Mesenchymal Transition
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
7. Neutron Capture Therapy
-
The epithelial-mesenchymal transition phenotype is associated with the frequency of tumor spread through air spaces (STAS) and a High risk of recurrence after resection of lung carcinoma
-
Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest
-
Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients
-
Effectiveness of tolvaptan and long-term prognosis in patients with liver cirrhosis
-
TAPO in first-line osimertinib therapy and continuation of osimertinib
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
-
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
-
Randomized Phase II Study of Gemcitabine Monotherapy vs. Gemcitabine with an EPAEnriched Oral Supplement in Advanced Pancreatic Cancer
-
泌尿器癌患者における骨吸収抑制剤関連顎骨壊死の発生頻度の検討
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Enhancement of antitumor immune response by radiation therapy combined with dual immune checkpoint inhibitor in a metastatic model of HER2-positive murine tumor
-
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
-
Proposed Definition for Oligometastatic Recurrence in Biliary Tract Cancer Based on Results of Locoregional Treatment: A Propensity-Score-Stratified Analysis
-
Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation-resistant pancreatic cancer
-
Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
-
Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer.
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Stromal reaction inhibitor and immune-checkpoint inhibitor combination therapy attenuates excluded-type colorectal cancer in a mouse model
-
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.
-
Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer
-
Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
TSC22D4/THG-1 suppresses cellular senescence in esophageal squamous cell carcinoma
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors